These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6267005)

  • 1. 6-beta-bromo- and 6-beta-iodo penicillanic acid, two novel beta-lactamase inhibitors.
    Wise R; Andrews JM; Patel N
    J Antimicrob Chemother; 1981 May; 7(5):531-6. PubMed ID: 6267005
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of inhibitors of beta-lactamases on beta-lactamase extracts and on intact cells.
    Li JT; Moosdeen F; Williams JD
    J Antimicrob Chemother; 1982 Apr; 9(4):287-96. PubMed ID: 6282800
    [No Abstract]   [Full Text] [Related]  

  • 3. Correlation of the effect of beta-lactamase inhibitors on the beta-lactamase in growing cultures of gram-negative bacteria with their effect on the isolated beta-lactamase.
    Easton CJ; Knowles JR
    Antimicrob Agents Chemother; 1984 Sep; 26(3):358-63. PubMed ID: 6095753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic activity of cefoperazone in combination with beta-lactamase inhibitors.
    Fu KP; Neu HC
    J Antimicrob Chemother; 1981 Mar; 7(3):287-92. PubMed ID: 6268598
    [No Abstract]   [Full Text] [Related]  

  • 5. In-vitro evaluation of sulbactam, a penicillanic acid sulphone with beta-lactamase inhibitory properties.
    Greenwood D; Eley A
    J Antimicrob Chemother; 1982 Aug; 10(2):117-23. PubMed ID: 6288651
    [No Abstract]   [Full Text] [Related]  

  • 6. Beta-lactamase inactivation by mechanism-based reagents.
    Fisher J; Belasco JG; Charnas RL; Khosla S; Knowles JR
    Philos Trans R Soc Lond B Biol Sci; 1980 May; 289(1036):309-19. PubMed ID: 6109326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of beta-lactamase inhibitors in chemotherapy.
    Neu HC
    Pharmacol Ther; 1985; 30(1):1-18. PubMed ID: 3018803
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of five irreversible inhibitors on beta-lactamase from Shigella flexneri UCSF-129.
    Campos M; Alarcón MA; González H; Sánchez R
    Microbios; 1993; 76(308):171-9. PubMed ID: 8302198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of four beta-lactamase inhibitors in combination with ampicillin against Mycobacterium tuberculosis.
    Sorg TB; Cynamon MH
    J Antimicrob Chemother; 1987 Jan; 19(1):59-64. PubMed ID: 3030999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibacterial activity of ampicillin alone and in combination with sulbactam correlated with beta-lactamase production.
    Chao HP; Ho SW; Luh KT; Hsieh WC
    Taiwan Yi Xue Hui Za Zhi; 1987 Mar; 86(3):241-7. PubMed ID: 3037003
    [No Abstract]   [Full Text] [Related]  

  • 11. Susceptibility of clinical isolates to expanded-spectrum beta-lactams alone and in the presence of beta-lactamase inhibitors.
    Qadri SM; Ueno Y; Cunha BA
    Chemotherapy; 1996; 42(5):334-42. PubMed ID: 8874972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clavulanic acid and CP-45,899: a comparison of their in vitro activity in combination with penicillins.
    Wise R; Andrews JM; Bedford KA
    J Antimicrob Chemother; 1980 Mar; 6(2):197-206. PubMed ID: 6247316
    [No Abstract]   [Full Text] [Related]  

  • 13. 6-(E)-acetylmethylenepenicillanic acid, a potent beta-lactamase inhibitor.
    Adam S; Then RL; Angehrn P
    J Antibiot (Tokyo); 1987 Jan; 40(1):108-9. PubMed ID: 3030991
    [No Abstract]   [Full Text] [Related]  

  • 14. Synthesis and beta-lactamase inhibitory properties of 2 beta-(chloromethyl)-2 alpha-methylpenam-3 alpha-carboxylic acid 1,1-dioxide.
    Gottstein WJ; Crast LB; Graham RG; Haynes UJ; McGregor DN
    J Med Chem; 1981 Dec; 24(12):1531-4. PubMed ID: 6273562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and beta-lactamase inhibitory properties of 2 beta-[(1,2,3-triazol-1-yl)methyl]-2 alpha-methylpenam-3 alpha-carboxylic acid 1,1-dioxide and related triazolyl derivatives.
    Micetich RG; Maiti SN; Spevak P; Hall TW; Yamabe S; Ishida N; Tanaka M; Yamazaki T; Nakai A; Ogawa K
    J Med Chem; 1987 Aug; 30(8):1469-74. PubMed ID: 3039137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanic acid and sulbactam combined with ampicillin and piperacillin against beta-lactamase producing anaerobic bacteria.
    Nord CE
    J Chemother; 1989 Jul; 1(4 Suppl):273-5. PubMed ID: 16312398
    [No Abstract]   [Full Text] [Related]  

  • 17. In-vitro susceptibility of the Bacteroides fragilis group to cefoperazone, ampicillin, ticarcillin and amoxycillin combined with beta-lactamase inhibitors.
    Barry AL; Jones RN; Packer RR
    J Antimicrob Chemother; 1986 Jan; 17(1):125-7. PubMed ID: 3005222
    [No Abstract]   [Full Text] [Related]  

  • 18. Tazobactam is a potent inactivator of selected inhibitor-resistant class A beta-lactamases.
    Bonomo RA; Rudin SA; Shlaes DM
    FEMS Microbiol Lett; 1997 Mar; 148(1):59-62. PubMed ID: 9066111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sulbactam and clavulanic acid: studies of enzyme kinetics and synergism with ampicillin and mezlocillin].
    Cullmann W; Binder S; Stieglitz M
    Immun Infekt; 1987 May; 15(3):103-9. PubMed ID: 3038733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-lactamase inhibition by acetylmethylene penicillanic acid compared to that of clavulanate and sulbactam.
    Chin NX; McElrath MJ; Neu HC
    Chemotherapy; 1988; 34(4):318-25. PubMed ID: 2850139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.